Evidence map›Paper›PMID 41733738›Full record

ArticleHuman genetics2026

Variants in NR6A1 as a cause for congenital renal, vertebral and uterine anomalies.

Adeline Jacquinet, Lydie Flasse, Manon Dohet, Romane Vanhaeren, Hélène Pendeville, Carol Saunders, Anna Lehman, Catherine Pienkowski, Karine Morcel, Daniel Guerrier and 2 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Adeline JacquinetGIGA-Human Genetics Laboratory, University of Liège, Liège, Belgium. adeline.jacquinet@chuliege.be.
Lydie FlasseGIGA-Laboratory of Zebrafish Development and Disease Models, University of Liège, Liège , Belgium.
Manon DohetGIGA-Laboratory of Zebrafish Development and Disease Models, University of Liège, Liège , Belgium.
Romane VanhaerenGIGA-Laboratory of Zebrafish Development and Disease Models, University of Liège, Liège , Belgium.
Hélène PendevilleGIGA-Zebrafish Facility, University of Liège, Liège, Belgium.
Carol SaundersDepartment of Pathology and Laboratory Medicine, Children's Mercy Hospital, University of Missouri Kansas City, School of Medicine, Kansas City, MO, 64108, USA.
Anna LehmanDepartment of Medical Genetics, University of British Columbia, BC Children's Hospital BC Women's Hospital, Vancouver, BC, Canada.
Catherine PienkowskiCentre Reference Pathologies Gynecologiques Rares, CHU Toulouse, 31059, Toulouse Cedex9, France.
Karine MorcelUniv. Brest, Inserm, UMR1304, GETBO; Department of Obstetrics and Gynecology, CHU Brest, 29200, Brest, France.
Daniel GuerrierUniv.Rennes, CNRS, IGDR (Institut de Génétique et Développement de Rennes) - UMR 6290, Rennes, France.
Vincent Bours *GIGA-Human Genetics Laboratory, University of Liège, Liège, Belgium.
Bernard Peers *GIGA-Laboratory of Zebrafish Development and Disease Models, University of Liège, Liège , Belgium. bpeers@uliege.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The underlying cause for renal and uterine agenesis remains unknown in many cases, whereas recurrence in some families strongly suggests the involvement of genetic factors. Here, we identify 5 affected individuals from 3 families with phenotypes including bilateral or unilateral renal agenesis/hypoplasia, along with variable congenital uterine anomalies and costovertebral defects associated with heterozygous deleterious variants in NR6A1. The variant spectrum includes two inherited missense (c.1175T>G;p.(Met392Arg) and c.196C>T;p.(Arg66Cys)) as well as de novo loss of function, with the latter associated with a perinatal lethal phenotype characterized by bilateral renal agenesis. In vitro studies demonstrated partial loss-of-function for both missense variants. To investigate the role of NR6A1 in development, CRISPR-Cas9 zebrafish mutants for the orthologs nr6a1a and nr6a1b were generated. Mutants recapitulate the human phenotype, exhibiting impaired kidney development, including pronephros segmentation defects and adult kidney hypoplasia, along with axial skeletal abnormalities, cloacal anomalies, and disrupted anteroposterior expression of posterior hox genes. This study provides strong evidence linking NR6A1 heterozygous deleterious variants to renal, uterine and costovertebral defects in humans.

Indexed as

Congenital AbnormalitiesKidneyKidney DiseasesNuclear Receptor Subfamily 6, Group A, Member 1SpineUrogenital AbnormalitiesUterusAnimalsFemaleHumansMaleMutation, MissensePedigreePhenotypeZebrafishNuclear Receptor Subfamily 6, Group A, Member 1Costovertebral defectsCRISPR-Cas9 zebrafish modelNr6a1a and nr6a1bNR6A1 variantsRenal agenesisUterine anomalies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.